Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Olanzapine in the treatment of schizophrenia : an open label comparative clinical trial from north India.

Avasthi A, Kulhara P, Kakkar N.

Indian J Psychiatry. 2001 Jul;43(3):257-63.

PMID:
21407865
[PubMed]
Free PMC Article
2.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

Tollefson GD, Beasley CM Jr, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.

Am J Psychiatry. 1997 Apr;154(4):457-65.

PMID:
9090331
[PubMed - indexed for MEDLINE]
3.

Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.

Takahashi H, Kamata M, Yoshida K, Ishigooka J, Higuchi H.

J Clin Psychiatry. 2006 Oct;67(10):1577-82.

PMID:
17107250
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.

Maciulis V, Bitter I, Milasiunas R, Dembinskas A, Radavicius L, Kaunas A, Dossenbach M, Walker D.

Curr Ther Res Clin Exp. 2004 Jan;65(1):57-69. doi: 10.1016/S0011-393X(04)90005-7.

PMID:
24936104
[PubMed]
Free PMC Article
5.

Olanzapine: an updated review of its use in the management of schizophrenia.

Bhana N, Foster RH, Olney R, Plosker GL.

Drugs. 2001;61(1):111-61. Review.

PMID:
11217867
[PubMed - indexed for MEDLINE]
6.

Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.

Gomez JC, Crawford AM.

J Clin Psychiatry. 2001;62 Suppl 2:6-11.

PMID:
11232753
[PubMed - indexed for MEDLINE]
7.

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.

Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.

BMC Psychiatry. 2005 Jan 13;5:3.

PMID:
15649317
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
[PubMed - indexed for MEDLINE]
9.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
[PubMed - indexed for MEDLINE]
10.

Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.

Bhowmick S, Hazra A, Ghosh M.

Aust N Z J Psychiatry. 2010 Mar;44(3):237-42. doi: 10.3109/00048670903487134.

PMID:
20050717
[PubMed - indexed for MEDLINE]
11.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
12.

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.

Tollefson GD, Sanger TM, Lu Y, Thieme ME.

Arch Gen Psychiatry. 1998 Mar;55(3):250-8. Erratum in: Arch Gen Psychiatry 1998 Nov;55(11):1052.

PMID:
9510219
[PubMed - indexed for MEDLINE]
13.

Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.

Breier A, Berg PH, Thakore JH, Naber D, Gattaz WF, Cavazzoni P, Walker DJ, Roychowdhury SM, Kane JM.

Am J Psychiatry. 2005 Oct;162(10):1879-87.

PMID:
16199834
[PubMed - indexed for MEDLINE]
14.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
15.

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.

Alvarez E, Bobes J, Gómez JC, Sacristán JA, Cañas F, Carrasco JL, Gascón J, Gibert J, Gutiérrez M; EUROPA Study Group.

Eur Neuropsychopharmacol. 2003 Jan;13(1):39-48.

PMID:
12480121
[PubMed - indexed for MEDLINE]
16.

The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine.

Dossenbach MRK, Beuzen JN, Avnon M, Belmaker RH, Elizur A, Mark M, Munitz H, Schneidman M, Shoshani D, Kratky P, Grundy SL, Tollefson GD.

Clin Ther. 2000 Sep;22(9):1021-34.

PMID:
11048902
[PubMed - indexed for MEDLINE]
17.

Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.

Dossenbach MR, Kratky P, Schneidman M, Grundy SL, Metcalfe S, Tollefson GD, Belmaker RH.

J Clin Psychiatry. 2001;62 Suppl 2:28-34.

PMID:
11232749
[PubMed - indexed for MEDLINE]
18.
19.

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM Jr.

Qual Life Res. 1999 Aug;8(5):417-26.

PMID:
10474283
[PubMed - indexed for MEDLINE]
20.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk